Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: A$0.31 M
• Last 3 months FTD volume: A$6.22 M
• Last year FTD volume: A$6.22 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	A$4.51 M	A$56.29 M	🇺🇸 USA
Royalty Pharma RPRX	A$6.38 M	A$12.36 M	🇬🇧 UK
Palatin Technologies PTN	A$0.13 M	A$2.23 M	🇺🇸 USA
Eli Lilly LLY	A$41.73 M	A$0.14 B	🇺🇸 USA
AbbVie ABBV	A$75.4 M	A$0.15 B	🇺🇸 USA
Pfizer PFE	A$50.21 M	A$0.38 B	🇺🇸 USA
ANI Pharmaceuticals ANIP	A$1.96 M	A$2.44 M	🇺🇸 USA
Athersys ATHX	A$0.09 M	A$0.71 M	🇺🇸 USA